Author:
Tack Véronique,Schuuring Ed,Keppens Cleo,Hart Nils ‘t,Pauwels Patrick,van Krieken Han,Dequeker Elisabeth M.C.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Cagle, P. T., Raparia, K. & Portier, B. P. Emerging biomarkers in personalized therapy of lung cancer. Adv. Exp. Med. Biol. 890, 25–36 (2016).
2. Pillai, R. K. et al. The state of the art in colorectal cancer molecular biomarker testing. Adv. Anat. Pathol. 23, 92–103 (2016).
3. Saijo, N. Critical comments for roles of biomarkers in the diagnosis and treatment of cancer. Cancer Treat. Rev. 38, 63–67f (2012).
4. Douillard, J. Y. et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. New Engl. J. Med. 369, 1023–1034 (2013).
5. European Medicine Agency (EMA). Erbitux: EPAR Summary for the Public (EMA, 2013)
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000558/WC500029119.pdf
.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献